Congress is on track to end its current session next week without addressing drug manufacturers’ denials of 340B pricing when covered entities contract with outside pharmacies.

117th Congress Nears End With No 340B Contract Pharmacy Fix Expected

In Federal, LegislativeDecember 15, 2022181 Views

Tom Mirga

The 117th Congress appears destined to end without further action on the 340B program.

The House and Senate are on track to finish all work for the year by no later than Friday, Dec. 23. According to news reports yesterday, they are expected to pass an omnibus appropriations bill to fund the entire government through Sept. 30, 2023, and then recess for the holidays.

The 117th Congress appears destined to end without further action on the 340B program.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

117th Congress Nears End With No 340B Contract Pharmacy Fix Expected

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

117th Congress Nears End With No 340B Contract Pharmacy Fix Expected

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Site Footer